Métastases leptoméningées dans le cancer du sein – État des lieux et perspectives
Open Access
- 28 May 2025
- journal article
- abstracts
- Published by Elsevier in Bulletin du Cancer
- Vol. 112 (7-8) , 838-852
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal DiseaseJAMA Oncology, 2024
- Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort studyBreast Cancer Research and Treatment, 2024
- Single‐cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastasesClinical and Translational Medicine, 2022
- Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal AdministrationClinical Pharmacology & Therapeutics, 2021
- Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastasesCancer Medicine, 2020
- Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survivalJournal of Neuro-Oncology, 2020
- Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across EuropeJournal of Neuro-Oncology, 2017
- Factors Associated With the Onset and Persistence of Post–Lumbar Puncture HeadacheJAMA Neurology, 2015
- Leptomeningeal disease and breast cancer: the importance of tumor subtypeBreast Cancer Research and Treatment, 2014
- Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepaJournal of Neuro-Oncology, 2013